Overview and Scope
The metoprolol tartrate market consists of sales of extended-release tablets,
lopressor, and intravenous formulations.
Values in this market are ‘factory gate’ values, that is the value of goods
sold by the manufacturers or creators of the goods, whether to other entities
(including downstream manufacturers, wholesalers, distributors and retailers)
or directly to end customers. The value of goods in this market includes
related services sold by the creators of the goods.
Sizing and Forecast
The metoprolol tartrate market size has grown strongly in recent years. It will
grow from $6.1 billion in 2023 to $6.41 billion in 2024 at a compound annual
growth rate (CAGR) of 5%. The growth in the historic period can be attributed
to rising awareness about hypertension, expansion and improvement of healthcare
systems, early patent protections, and health initiatives.
The metoprolol tartrate market size is expected to see strong growth in the
next few years. It will grow to $7.83 billion in 2028 at a compound annual
growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed
to personalized medicine, enhanced medical education and training on the
management of cardiovascular diseases, development of efficient drug
distribution networks, patient education programs and increased funding for
cardiovascular research. Major trends in the forecast period include consumer
behavior analysis, supply chain optimization, development of 3D printing
technologies for customizable drug formulations, increasing development and use
of mobile health apps.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/metoprolol-tartrate-global-market-report
Segmentation & Regional Insights
The metoprolol tartrate market covered in this report is segmented –
1) By Route of Administration: Oral, Injectable
2) By Application: Hypertension, Cardiovascular, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online
Pharmacies
North America was the largest region in the metoprolol tartrate market in 2023.
Asia-Pacific is expected to be the fastest-growing region in the forecast
period. The regions covered in the metoprolol tartrate market report are
Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of
the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16477&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of hypertension is expected to propel the growth of
the metoprolol tartrate market going forward. Hypertension is a complex
condition with multiple contributing factors. It can develop gradually due to
lifestyle and genetic factors, or other underlying health conditions can cause
it. The increasing prevalence of hypertension combines factors such as poor
diet, lack of physical activity, obesity, stress, and an aging population.
Metoprolol tartrate helps to manage hypertension by slowing the heart rate and
reducing the force the heart pumps, leading to lower blood pressure. For
instance, in December 2023, according to the Australian Bureau of Statistics,
in 2022, over one in ten (11.6% or 3.0 million) people reported having
hypertension. Additionally, in August 2021, according to the World Health
Organization, a Switzerland-based Intergovernmental organization and Imperial
College London joint press release, the number of adults aged 30–79 with hypertension
increased from 650 million to 1.28 billion in the last thirty years. Therefore,
the increasing prevalence of hypertension is driving the metoprolol tartrate
market.
Impact Of Increasing Coronary Heart Disease Prevalence On The Metoprolol
Tartrate Market
The increasing prevalence of coronary heart disease is expected to propel the
growth of the metoprolol tartrate market going forward. Coronary heart disease
is a condition characterized by the narrowing of the heart's blood vessels due
to plaque buildup, leading to decreased blood flow to the heart muscle and
potential heart problems such as chest pain or heart attack. Coronary heart
disease is caused by sedentary lifestyles, unhealthy dietary habits, smoking,
obesity, high blood pressure, and diabetes, which contribute to the development
and progression of this condition. Metoprolol tartrate helps manage coronary
heart disease by reducing heart rate and blood pressure, preventing angina,
protecting against acute coronary events, improving long-term outcomes, and
managing arrhythmias. For instance, in December 2023, according to the
Australian Bureau of Statistics, an Australian-based government administration,
in 2020-21, an estimated 571,000 Australians aged 18 and over (2.9% of the
adult population) were living with coronary heart disease. The prevalence of
CHD increases rapidly with age, affecting around 1 in 9 (11%) adults aged 75
and over. Therefore, the increasing prevalence of coronary heart disease is
driving the metoprolol tartrate market.
Key Industry Players
Major companies operating in the metoprolol tartrate market are Pfizer Inc.,
AstraZeneca plc, Novartis AG, Viatris Inc., Teva Pharmaceutical Industries
Ltd., Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Intas
Pharmaceuticals Ltd., Aurobindo Pharma, Cipla Inc., Hikma Pharmaceuticals PLC,
Amneal Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Emcure Pharmaceuticals
Ltd., Alembic Pharmaceuticals Inc., Accord Healthcare Inc., Beximco
Pharmaceuticals Ltd., Micro Labs Ltd., Inventia Healthcare Pvt. Ltd., Watson
Laboratories Inc., Aizant Drug Research Solutions Pvt. Ltd., Zydus Cadila,
Validus Pharmaceuticals LLC, Strides Pharma Science Limited, APO-MEDIX Pty Ltd.
The metoprolol tartrate market report table of contents includes:
1. Executive Summary
2.
Metoprolol Tartrate Market Characteristics
3.
Metoprolol Tartrate Market Trends And Strategies
4.
Metoprolol Tartrate Market - Macro Economic Scenario
5. Global
Metoprolol Tartrate Market Size and Growth
.
32. Global
Metoprolol Tartrate Market Competitive Benchmarking
33. Global
Metoprolol Tartrate Market Competitive Dashboard
34. Key
Mergers And Acquisitions In The Metoprolol Tartrate Market
35.
Metoprolol Tartrate Market Future Outlook and Potential Analysis
36.
Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment